Search Legislation

2002/106/EC: Commission DecisionShow full title

2002/106/EC: Commission Decision of 1 February 2002 approving a Diagnostic Manual establishing diagnostic procedures, sampling methods and criteria for evaluation of the laboratory tests for the confirmation of classical swine fever (Text with EEA relevance) (notified under document number C(2002) 381)

 Help about what version

What Version

 Help about advanced features

Advanced Features

More Resources

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes to legislation:

There are currently no known outstanding effects by UK legislation for 2002/106/EC: Commission Decision, CHAPTER III. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

CHAPTER IIIU.K.Guidelines on main criteria to be considered for the recognition of a holding as a classical swine fever suspected holding

The decision to recognise a holding as a suspected holding will be taken on the basis of the following findings, criteria and grounds:

(a)

clinical and pathological findings in pigs. The main clinical and pathological findings to be considered are:

  • fever with increased morbidity and mortality;

  • fever with haemorrhagic syndrome;

  • fever with neurological symptoms;

  • fever of unknown origin where treatment with antibiotics failed to improve the health state;

  • abortions and increased fertility problems during the last three months;

  • congenital tremor of piglets;

  • chronically diseased animals;

  • growth retarded (runted) young animals;

  • petechial and ecchymotic haemorrhages, especially in lymph nodes, kidneys, spleen, bladder and larynx;

  • infarction or haematomas, notably in the spleen;

  • button ulcers in the large intestine of chronic cases, particularly near the ileo-caecal junction.

(b)

epidemiological findings. The main epidemiological findings to be considered are:

  • where pigs had direct or indirect contact to a pig holding proven to have been infected with classical swine fever;

  • where a holding has supplied pigs that were subsequently shown to be infected with classical swine fever;

  • where sows have been artificially inseminated with semen originating from a suspect source;

  • where there has been indirect or direct contact with feral pigs of a population where classical swine fever occurs;

  • where pigs are kept outdoors in a region where feral pigs are infected with classical swine fever;

  • where pigs have been fed with swill and there is the suspicion that this swill has not been treated in such a way as to inactivate classical swine fever virus;

  • where possible exposure might have occurred, e.g. due to persons entering the holding, transports, etc.

(c)

findings related to results of serological tests. The main laboratory findings to be considered are:

  • serological reaction caused by an unnoticed classical swine fever virus infection or by vaccination(1);

  • cross-reaction between antibodies to classical swine fever and to other pestiviruses(2);

  • detection of singleton reactors(3).

(1)

If pigs have been vaccinated against classical swine fever with a conventional vaccine they can be found seropositive due to the vaccination alone, or due to a silent infection in vaccinated animals.

(2)

Under certain circumstances up to 10 % of the pigs within a herd may have antibodies against ruminant pestiviruses causing bovine viral diarrhoea and border disease. For example, when pigs have direct contact with cattle or sheep infected with BVD virus or BD virus, or when pigs have contact with materials contaminated with ruminant pestiviruses.

(3)

In all of the current serological tests for classical swine fever a small proportion of sera give false/positive results either due to the lack of specificity of the test-system or due to sera from the singleton reactors.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources